Mesenchymal stem cell therapy in acute lung injury: is it time for a clinical trial? | Thorax

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article info

Editorial

Mesenchymal stem cell therapy in acute lung injury: is it time for a clinical trial?

Free

Authors

Rob Mac Sweeney PubMed articles Google scholar articles
Daniel Francis McAuley PubMed articles Google scholar articles

Correspondence to Dr Daniel F McAuley, Centre for Infection and Immunity, Queen's University Belfast, Health Sciences Building, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland; d.f.mcauley{at}qub.ac.uk

Citation

Mac Sweeney R, McAuley DF

Mesenchymal stem cell therapy in acute lung injury: is it time for a clinical trial?

Thorax 2012;67:475-476.

Publication history

First published April 13, 2012.

Online issue publication

September 01, 2022

Article Versions

Previous version (29 April 2016).
You are viewing the most recent version of this article.

View clinical trial registration.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.